StockNews.com Initiates Coverage on Nabriva Therapeutics (NASDAQ:NBRV)
Equities research analysts at StockNews.com assumed coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Stock Performance Nabriva Therapeutics has a 1 year low of $1.22 and a 1 year high of $8.45. […]
Equities research analysts at StockNews.com assumed coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Stock Performance Nabriva Therapeutics has a 1 year low of $1.22 and a 1 year high of $8.45. […]
